Penn bioethicst challenges scientists to lead the public in discussions about their work

June 15, 2006

(Philadelphia, PA) -- In the first-ever article on bioethics to appear in Cell, one of the nation's leading bioethicists challenges scientists to proactively engage the public in discussions about the value and significance of their research protocols ... to maintain an ethical base, at all times, in the conduct of their own research ... and to help advance scientific knowledge among the public and their colleagues by freely sharing new and relevant information.

In a special "Commentary" penned exclusively for the journal Cell, Paul Root Wolpe, PhD, of the Center for Bioethics and Department of Psychiatry at the University of Pennsylvania School of Medicine, identifies the eight top reasons scientists cite to avoid thinking about ethics ... and then offers substantive responses to invalidate the scientists' excuses. Four of the eight reasons cited include: "I'm Not Trained in Ethics," "My...Work has Little to Do With Ethics," "Ethics is Arbitrary," and "Others will Make the Ethical Decisions." According to Wolpe, "Science is a powerful force for change in modern society. As the professionals at its helm, scientists have a unique responsibility to shepherd that change with thoughtful advocacy of their research and careful ethical scrutiny of their own behavior."

Wolpe argues that by becoming effective advocates for their work, scientists not only advance their own research pursuits but also the public's understanding and acceptance of various forms of inquiries. He notes that "the cloning of Dolly has become the exemplar of the failure to prepare the public for a scientific breakthrough...Had the ethical discussion kept pace with the research, the global hyperventilation over Dolly might well not have taken place."

If scientists continue to find reasons to not engage the public in a discussion of their activities, the public will find ways to scrutinize their behavior - "...and the results," cautions Wolpe, "may not always be in the best interests of science or society."
-end-
Editor's Note:
To schedule an interview with Dr. Wolpe, contact Kate Olderman at 215-349-8369.

PENN Medicine is a $2.9 billion enterprise dedicated to the related missions of medical education, biomedical research, and high-quality patient care. PENN Medicine consists of the University of Pennsylvania School of Medicine (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System.

Penn's School of Medicine is ranked #2 in the nation for receipt of NIH research funds; and ranked #3 in the nation in U.S. News & World Report's most recent ranking of top research-oriented medical schools. Supporting 1,400 fulltime faculty and 700 students, the School of Medicine is recognized worldwide for its superior education and training of the next generation of physician-scientists and leaders of academic medicine.

The University of Pennsylvania Health System includes three hospitals [Hospital of the University of Pennsylvania, which is consistently ranked one of the nation's few "Honor Roll" hospitals by U.S. News & World Report; Pennsylvania Hospital, the nation's first hospital; and Penn Presbyterian Medical Center]; a faculty practice plan; a primary-care provider network; two multispecialty satellite facilities; and home care and hospice.

University of Pennsylvania School of Medicine

Related Bioethics Articles from Brightsurf:

Unknowns and uncertainties raise ethical concerns for UK egg freezing
A lack of clear, accessible, and transparent data creates a series of ethical issues for egg freezing, according to a new briefing note from the Nuffield Council on Bioethics.

Tackling the bioethics challenges raised by COVID-19
The diverse situations experienced by health-care workers during the COVID-19 pandemic often present serious ethical challenges.

Yale-developed scorecard promotes better clinical trial data sharing
A tool developed by researchers at Yale, Stanford, and Bioethics International can promote greater sharing of clinical trial data by pharmaceutical companies.

Digging into new ethical issues around stem cells
Discussions concerning to the ethical issues related to stem cells have been ongoing for many years, but a special section in the latest issue of Perspectives in Biology and Medicine takes a deep look at some of the newest and most complex issues -- including the direct global sales of services and untested and unproven products marketed as stem cells.

The big ethical questions for artificial intelligence in healthcare
AI in healthcare is developing rapidly, with many applications currently in use or in development in the UK and worldwide.

Coding at birth: Nuffield Council on Bioethics publishes briefing note on whole genome sequencing of babies
The Nuffield Council on Bioethics has today published a briefing note that examines the ethical issues raised by whole genome sequencing of babies.

Insight into the challenges and contributions of nurse bioethicists
Nurse bioethicists are a small but special subset of the nursing profession and bioethics community, focusing on the moral complexities that arise in clinical care, research, and health policy.

Data indicate significant impact of NIH African bioethics training programs
A study published in BMJ Open looks back on 10 bioethics training programs funded by the Fogarty International Center at the US National Institutes of Health.

Johns Hopkins bioethics scholar elected to National Academy of Medicine
Jeffrey P. Kahn, PhD, MPH, the Andreas C. Dracopoulos Director of the Johns Hopkins Berman Institute of Bioethics, has been elected to the National Academy of Medicine.

Assessing the intangible
Bioethics scholars at Johns Hopkins create a checklist to help assess respect and patient dignity in the ICU.

Read More: Bioethics News and Bioethics Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.